TrialInternational journal of hematology2020

FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group.

Tadashi Kumamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.